IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
July 31, 2019 09:44 ET
|
Schall Law
LOS ANGELES, July 31, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Oasmia Pharmaceutical AB...
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
July 24, 2019 09:55 ET
|
Schall Law
LOS ANGELES, July 24, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Oasmia...
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Oasmia Pharmaceutical AB and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
July 19, 2019 16:30 ET
|
Schall Law
LOS ANGELES, July 19, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Oasmia...
Bragar Eagel & Squire, P.C. is Investigating Oasmia Pharmaceutical AB (NASDAQ: OASM) on Behalf of Stockholders and Encourages Investors to Contact the Firm
July 11, 2019 21:30 ET
|
Bragar Eagel & Squire
NEW YORK, July 11, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. is investigating potential claims against Oasmia Pharmaceutical AB (NASDAQ: OASM) on behalf of Oasmia investors. Our...